E3 PreliminaryPreliminaryPEM unclearReview-NarrativePeer-reviewedMachine draft
The Role of Microbiota and Intestinal Permeability in the Pathophysiology of Autoimmune and Neuroimmune Processes with an Emphasis on Inflammatory Bowel Disease Type 1 Diabetes and Chronic Fatigue Syndrome.
Morris, Gerwyn, Berk, Michael, Carvalho, André F et al. · Current pharmaceutical design · 2016 · DOI
Quick Summary
This review explores how problems with the gut barrier and changes in gut bacteria may trigger widespread immune activation and brain inflammation in ME/CFS and other autoimmune diseases. When the intestinal lining becomes more permeable (leaky), bacteria and their products can enter the bloodstream, potentially causing the fatigue, brain fog, and other symptoms characteristic of ME/CFS.
Why It Matters
This work provides a unifying biological hypothesis for ME/CFS pathophysiology, linking gastrointestinal dysfunction to both systemic immune dysregulation and neurological symptoms. For researchers, it synthesizes evidence suggesting gut-targeted interventions and intestinal permeability measurements may be relevant biomarkers and therapeutic targets in ME/CFS.
Observed Findings
- Intestinal immune homeostasis is maintained through bidirectional communication between microbiota and the gut immune system
- Breakdown of intestinal barrier function is associated with translocation of commensal antigens into systemic circulation
- Dysbiosis and increased intestinal permeability are implicated in Th17/Treg cell imbalances in autoimmune diseases
- Increased intestinal permeability may contribute to the severe fatigue and neurocognitive symptoms in ME/CFS
Inferred Conclusions
- Gut dysbiosis and resulting increased intestinal permeability may be a common upstream mechanism driving systemic immune activation in both autoimmune and neuroimmune diseases
- Antigen translocation from the compromised gut barrier is proposed as a mechanism linking gastrointestinal dysfunction to the diverse symptom presentations in ME/CFS
- Genetic and environmental factors, combined with breakdown of intestinal immune homeostasis, likely work together in disease pathophysiology
Remaining Questions
- What are the primary causative factors of dysbiosis and barrier dysfunction in ME/CFS—viral infection, toxins, genetic predisposition, or a combination?
- Does correction of intestinal permeability and dysbiosis improve clinical outcomes in ME/CFS patients?
What This Study Does Not Prove
This review does not provide experimental evidence that intestinal permeability or dysbiosis causes ME/CFS—it is a mechanistic hypothesis based on synthesis of existing literature. The study does not establish causation, distinguish whether gut changes are primary or secondary to ME/CFS, or provide clinical outcome data validating proposed mechanisms in ME/CFS patients specifically.
Tags
Symptom:Cognitive DysfunctionFatigue
Biomarker:CytokinesAutoantibodies
Method Flag:Weak Case DefinitionExploratory Only
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →